Penserra Capital Management LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1593324
ORINDA, CA
Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$33,766
+$1,362 QoQ
Shares Held
726
-40.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#251
of 331 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $11,877,521 across 6 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
101,095 | $3,504,963 | |
| 2 | LQDA |
Liquidia Corp
|
41,405 | $3,301,220 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
30,226 | $1,932,952 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
43,098 | $1,768,310 | |
| 5 | ZTS |
Zoetis Inc.
|
18,632 | $1,336,310 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
726 | $33,766 |
All Filings in SUPN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,766 | 726 | Shares | Defined | 2026-08-13 | |
| 2021-09-30 | $32,404 | 1,215 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,101 | 1,205 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $31,154 | 1,190 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $30,443 | 1,210 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,419 | 452 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||